David Floch

647 total citations
5 papers, 415 citations indexed

About

David Floch is a scholar working on Hematology, Rheumatology and Molecular Biology. According to data from OpenAlex, David Floch has authored 5 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 3 papers in Rheumatology and 2 papers in Molecular Biology. Recurrent topics in David Floch's work include Autoimmune and Inflammatory Disorders Research (4 papers), Inflammasome and immune disorders (2 papers) and Urticaria and Related Conditions (1 paper). David Floch is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (4 papers), Inflammasome and immune disorders (2 papers) and Urticaria and Related Conditions (1 paper). David Floch collaborates with scholars based in Switzerland, United States and India. David Floch's co-authors include Philip J. Lowe, Abhijit Chakraborty, Andrej Skerjanec, Sandip Kumar Roy, Hermann Gram, Stacey Tannenbaum, Christiane Rordorf, Suzanne Maahs, A. Groenewegen and Claire Owen and has published in prestigious journals such as Clinical Pharmacokinetics, Clinical & Experimental Allergy and The Journal of Clinical Pharmacology.

In The Last Decade

David Floch

5 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Floch Switzerland	5	138	125	116	114	97	5	415
E. Prati Italy	11	109 0.8×	38 0.3×	137 1.2×	156 1.4×	51 0.5×	21	516
C B Wilson United States	9	248 1.8×	57 0.5×	114 1.0×	67 0.6×	67 0.7×	13	615
K.J.M. Assmann Netherlands	10	194 1.4×	33 0.3×	70 0.6×	195 1.7×	48 0.5×	12	448
F D'Alessandro Italy	8	165 1.2×	91 0.7×	101 0.9×	34 0.3×	13 0.1×	16	418
Sandra M. J. Paulissen Netherlands	9	318 2.3×	149 1.2×	69 0.6×	189 1.7×	11 0.1×	13	576
E. A. M. Van Der Voort Netherlands	12	275 2.0×	33 0.3×	99 0.9×	271 2.4×	24 0.2×	15	539
Alfredo Colombo Italy	11	147 1.1×	133 1.1×	40 0.3×	30 0.3×	105 1.1×	26	408
Tiantian Ma China	11	182 1.3×	80 0.6×	132 1.1×	64 0.6×	27 0.3×	29	434
Florence Anquetil United States	9	168 1.2×	17 0.1×	83 0.7×	229 2.0×	43 0.4×	11	552
Alessandra Zanola Italy	9	101 0.7×	44 0.4×	88 0.8×	174 1.5×	10 0.1×	11	365

Countries citing papers authored by David Floch

Since Specialization

Citations

This map shows the geographic impact of David Floch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Floch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Floch more than expected).

Fields of papers citing papers by David Floch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Floch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Floch. The network helps show where David Floch may publish in the future.

Co-authorship network of co-authors of David Floch

This figure shows the co-authorship network connecting the top 25 collaborators of David Floch. A scholar is included among the top collaborators of David Floch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Floch. David Floch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Lindgren, S., et al.. (2018). Bioequivalence of Canakinumab Injected Subcutaneously via an Autoinjector Device or a Prefilled Safety Syringe Device in Healthy Subjects. Clinical Pharmacology in Drug Development. 7(8). 829–836. 6 indexed citations

2.

Sun, Haiying, David Floch, Xuemin Jiang, et al.. (2016). Pharmacokinetics and Pharmacodynamics of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis. The Journal of Clinical Pharmacology. 56(12). 1516–1527. 34 indexed citations

3.

Skerjanec, Andrej, David Floch, A. Groenewegen, et al.. (2014). Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high‐affinity anti‐IgE antibody, in atopic subjects. Clinical & Experimental Allergy. 44(11). 1371–1385. 190 indexed citations

4.

Chakraborty, Abhijit, Andrej Skerjanec, David Floch, et al.. (2013). Pharmacokinetic and pharmacodynamic properties of canakinumab in patients with gouty arthritis. The Journal of Clinical Pharmacology. 53(12). 1240–1251. 31 indexed citations

5.

Chakraborty, Abhijit, Stacey Tannenbaum, Christiane Rordorf, et al.. (2012). Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody. Clinical Pharmacokinetics. 51(6). e1–e18. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact